Edward A Clark|Andrew Craxton

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Edward A Clark

Andrew Craxton

Immunity

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Immunity|June 24, 2003

A CD40 bridge between innate and adaptive immunityEdward A Clark, Andrew Craxton

Immunity|November 15, 2003

Branches of the B cell antigen receptor pathway are directed by protein conduits Bam32 and Carma1Hiroaki Niiro, Edward A Clark

Immunity|July 31, 2012

The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitnessMehul S Suthar, Hilario J Ramos, Margaret M Brassil, et al.

Immunity|May 24, 2024

A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell deathJonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Immunity|June 24, 2003

A CD40 bridge between innate and adaptive immunityEdward A Clark, Andrew Craxton

Immunity|November 15, 2003

Branches of the B cell antigen receptor pathway are directed by protein conduits Bam32 and Carma1Hiroaki Niiro, Edward A Clark

Immunity|July 31, 2012

The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitnessMehul S Suthar, Hilario J Ramos, Margaret M Brassil, et al.

Immunity|May 24, 2024

A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell deathJonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.

Pageof 1